Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Pharming Group N.V. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +3 vs. Q1 2026
- Shares held
- 95.2K
- +9.40K (+11.0%) vs. Q1 2026
- Total value
- $1.31M
- −$113.6K (−8.0%) vs. Q1 2026
- New holders
- 6
- 3 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $1.31M |
| Q1 2026 | 13 | $1.43M |
| Q4 2025 | 11 | $2.48M |
| Q3 2025 | 9 | $857.3K |
| Q2 2025 | 4 | $629.6K |
| Q1 2025 | 4 | $434.0K |
| Q4 2024 | 5 | $514.3K |
| Q3 2024 | 4 | $369.2K |
| Q2 2024 | 4 | $230.4K |
| Q1 2024 | 3 | $274.7K |
| Q4 2023 | 2 | $266.4K |
| Q3 2023 | 3 | $295.6K |
| Q2 2023 | 2 | $290.8K |
| Q1 2023 | 3 | $295.6K |
| Q4 2022 | 3 | $325.1K |
| Q3 2022 | 3 | $245.0K |
| Q2 2022 | 3 | $180.0K |
| Q1 2022 | 4 | $184.0K |
| Q4 2021 | 3 | $166.0K |
| Q3 2021 | 4 | $249.0K |
| Q2 2021 | 7 | $2.24M |
| Q1 2021 | 3 | $2.46M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Pharming Group N.V.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | 41,547 | $577.1K | 0.22% | −3,200−7.2% | Reduced |
| Crossmark Global Holdings, Inc. | 12,463 | $169.0K | 0.00% | +12,463 | New |
| Citadel Advisors LLC | 11,972 | $162.3K | 0.00% | +1,783+17.5% | Added |
| Morgan Stanley | 11,500 | $159.7K | 0.00% | +11+0.1% | Added |
| SmartHarvest Portfolios, LLC | 10,415 | $144.7K | 0.05% | −382−3.5% | Reduced |
| Knoll Capital Management, LLC | 4,091 | $56.8K | 0.03% | +34+0.8% | Added |
| Silver Grove Financial Group, Inc. | 1,071 | $14.9K | 0.01% | +1,071 | New |
| Nalls Sherbakoff Group, LLC | 870 | $12.1K | 0.01% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 456 | $6.33K | 0.00% | +456 | New |
| BNP Paribas Arbitrage, SA | 300 | $4.17K | 0.00% | −100−25.0% | Reduced |
| Optiver Holding B.V. | 305 | $4.14K | 0.00% | +305 | New |
| GWM Advisors LLC | 187 | $2.60K | 0.00% | −1,963−91.3% | Reduced |
| UBS Group AG | 39 | $542 | 0.00% | +39 | New |
| Advisor Group Holdings, Inc. | 16 | $222 | 0.00% | −112−87.5% | Reduced |
| Larson Financial Group LLC | 7 | $97 | 0.00% | −336−98.0% | Reduced |
| Caitong International Asset Management Co., Ltd | 1 | $14 | 0.00% | +1 | New |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −557−100.0% | Sold out |
| Stone House Investment Management, LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Cornerstone Financial Management LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |